Mersana Therapeutics, Inc.MRSNNASDAQ
LOADING
|||
EBITDA Over Time
Trending higher, above historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-63.27M
↑ 25% above average
Average (9y)
$-84.11M
Historical baseline
Range
High:$-13.17M
Low:$-199.96M
CAGR
+16.5%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-63.27M | +61.9% |
| 2023 | $-166.08M | +16.9% |
| 2022 | $-199.96M | -19.1% |
| 2021 | $-167.94M | -92.8% |
| 2020 | $-87.10M | -225.9% |
| 2019 | $-26.73M | +57.6% |
| 2018 | $-63.00M | -66.8% |
| 2017 | $-37.78M | -186.9% |
| 2016 | $-13.17M | +17.9% |
| 2015 | $-16.04M | - |